M

Madrigal Pharmaceuticals

Biopharmaceutical firm developing NASH therapies

Senior Director, Commercial Advanced Analytics - Advanced Analytics Products

Data & AnalyticsUpdated on Nov 16
Full-timeIn-person

About the Job

Requirements

  • A bachelor's degree in a quantitative field such as statistics, data science, computer science, or engineering is required.
  • At least 15 years of pharmaceutical or biotech commercial advanced analytics experience, with demonstrated value generation across Sales, Patient Services, Market Access, and Marketing, such as omni-channel, attrition modeling, or shareshift, is required.
  • Fluency with core commercial data assets, including specialty pharmacy or hub, claims such as IQVIA and Symphony, CRM or Veeva, call and activity data, and consent data, as well as the governed semantic layer built on them, is required.
  • Experience partnering with technical teams to bring machine-learning and AI-driven tools into production commercial workflows, with working knowledge of MLOps and model lifecycle management, is required.
  • Demonstrated experience building, leading, and developing analytics or data science teams is required.
  • Hands-on proficiency in Python and SQL, and experience with cloud data and machine-learning platforms such as Databricks, Fabric, and Azure or AWS ML tooling, is required.
  • Deep fluency in the commercial operating model, including field and home-office orchestration, market access, brand performance, and patient-services workflow optimization, paired with technical grounding and judgment to prioritize high-ROI use cases, is required.
  • The ability to build trust and evaluation rigor around new AI capabilities with non-technical stakeholders is required.
  • Effective cross-functional partnership across Commercial, Medical, IT, and the enterprise AI team, including translating business needs into technical requirements, is required.
  • Proven people leadership and team development is required.

Responsibilities

  • Serve as the Commercial point of contact for defining and prioritizing the roadmap of commercial advanced analytics and AI use cases in partnership with Commercial leadership and the enterprise AI team, which builds and deploys them on the enterprise platform.
  • Own the advanced analytics roadmap and business integration of the next-best-action and omni-channel strategy, focusing on improving customer engagement through field and home-office orchestration.
  • Prioritize and manage the Commercial advanced-analytics and AI use-case pipeline in alignment with the enterprise intake, prioritization, and governance process.
  • Define business, data, and success requirements for Commercial models and AI tools, and partner with enterprise AI and IT on deployment and optimization.
  • Provide commercial validation and business acceptance during enterprise-run testing and phased rollouts, apply the enterprise evaluation framework, and feed Commercial requirements back to enterprise AI.
  • Own day-to-day advanced analytics operations by serving as intake for Commercial leadership requests, structuring problem statements, working with dedicated Commercial Analytics AI resources on the Enterprise AI team to build appropriate solutions, and synthesizing results into business-facing insights.
  • Develop requirements for the Commercial Data Products team to enhance the semantic layer for trusted self-service, democratization of model outputs, and forward-looking natural-language querying.
  • Serve as the Commercial-domain expert who translates business needs into advanced analytics and AI solutions, and represent Commercial requirements in enterprise AI tool vendor evaluations.

Desired Qualifications

  • An advanced degree (MS or PhD) is preferred.
  • Experience applying evaluation and phased-rollout approaches, such as shadow mode, for AI tools deployed on an enterprise platform is preferred.
  • Experience supporting specialty or rare-disease brands is preferred.
  • Proven success deploying AI workflow enhancements with a focus on return on investment is preferred.

About the Company

Madrigal Pharmaceuticals

Biopharmaceutical firm developing NASH therapies

Madrigal Pharmaceuticals develops therapies for nonalcoholic steatohepatitis (NASH) and related liver diseases, focusing on patients with moderate to advanced fibrosis and compensated cirrhosis. Its first therapy has FDA accelerated approval and is in Phase 3 trials, with revenue from sales and potential partnerships. The exact mechanism of action isn’t detailed, but the product has demonstrated clinical benefit in trials and ongoing safety validation. The company differentiates itself by a focused NASH program with accelerated approval and continued Phase 3 development, plus possible licensing deals, aiming to bring approved treatments to patients.

Company size
1,001-5,000
Company stage
IPO
Headquarters
West Conshohocken, PA
Founded
2011

Recently Posted Jobs

Explore more opportunities at Madrigal Pharmaceuticals

See more jobs